Published in BMC Med Res Methodol on January 12, 2007
Multivariate meta-analysis: potential and promise. Stat Med (2011) 5.26
Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med (2012) 2.52
Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38
Cognitive ontologies for neuropsychiatric phenomics research. Cogn Neuropsychiatry (2009) 1.59
Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza Other Respir Viruses (2011) 1.55
Reducing and meta-analysing estimates from distributed lag non-linear models. BMC Med Res Methodol (2013) 1.45
Multivariate Meta-Analysis of Genetic Association Studies: A Simulation Study. PLoS One (2015) 1.38
Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One (2013) 1.34
Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds. BMC Med Res Methodol (2009) 1.32
Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. CMAJ (2013) 1.32
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med (2012) 1.23
Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med (2015) 1.20
A matrix-based method of moments for fitting the multivariate random effects model for meta-analysis and meta-regression. Biom J (2013) 1.16
Meta-analysis in medical research. Hippokratia (2010) 1.14
Bivariate random effects meta-analysis of diagnostic studies using generalized linear mixed models. Med Decis Making (2009) 1.07
Multivariate meta-analysis of mixed outcomes: a Bayesian approach. Stat Med (2013) 1.05
Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: methods for the absolute risk difference and relative risk. Stat Methods Med Res (2010) 1.00
Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care (2014) 0.95
Multivariate meta-analysis using individual participant data. Res Synth Methods (2014) 0.94
Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse data. Stat Methods Med Res (2015) 0.94
Chapter 8: meta-analysis of test performance when there is a "gold standard". J Gen Intern Med (2012) 0.93
A correlated meta-analysis strategy for data mining "OMIC" scans. Pac Symp Biocomput (2013) 0.87
Analyzing multiple outcomes in clinical research using multivariate multilevel models. J Consult Clin Psychol (2014) 0.87
Statistical methods for multivariate meta-analysis of diagnostic tests: An overview and tutorial. Stat Methods Med Res (2013) 0.86
Meta-analysis of test accuracy studies: an exploratory method for investigating the impact of missing thresholds. Syst Rev (2015) 0.82
Network meta-analysis of multiple outcome measures accounting for borrowing of information across outcomes. BMC Med Res Methodol (2014) 0.82
Individual patient data meta-analysis for the clinical assessment of coronary computed tomography angiography: protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT). Syst Rev (2013) 0.82
Two-stage meta-analysis of survival data from individual participants using percentile ratios. Stat Med (2012) 0.80
Joint synthesis of multiple correlated outcomes in networks of interventions. Biostatistics (2014) 0.80
Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement. Stat Med (2015) 0.78
A double SIMEX approach for bivariate random-effects meta-analysis of diagnostic accuracy studies. BMC Med Res Methodol (2017) 0.77
mmeta: An R Package for Multivariate Meta-Analysis. J Stat Softw (2014) 0.77
An alternative pseudolikelihood method for multivariate random-effects meta-analysis. Stat Med (2014) 0.77
An Empirical Bayes Method for Multivariate Meta-analysis with an Application in Clinical Trials. Commun Stat Theory Methods (2014) 0.77
Meta-analysis of haplotype-association studies: comparison of methods and empirical evaluation of the literature. BMC Genet (2011) 0.77
Synthesis of clinical prediction models under different sets of covariates with one individual patient data. BMC Med Res Methodol (2015) 0.77
Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process. Stat Med (2015) 0.76
Inference for correlated effect sizes using multiple univariate meta-analyses. Stat Med (2015) 0.75
Diagnostic accuracy of fine needle aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a systematic review and meta-analysis. Syst Rev (2015) 0.75
The choice of prior distribution for a covariance matrix in multivariate meta-analysis: a simulation study. Stat Med (2015) 0.75
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol (2005) 10.56
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med (2002) 6.53
A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics (2006) 3.23
Meta-analysis of multiple outcomes by regression with random effects. Stat Med (1998) 2.56
A likelihood approach to meta-analysis with random effects. Stat Med (1996) 2.54
Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol (2006) 2.45
On meta-analytic assessment of surrogate outcomes. Biostatistics (2000) 2.41
Meta-analysis for the evaluation of potential surrogate markers. Stat Med (1997) 2.22
An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat Med (2007) 2.11
Meta-analysis of multitreatment studies. Med Decis Making (1998) 2.09
Assessing surrogates as trial endpoints using mixed models. Stat Med (2005) 1.94
Valid inference in random effects meta-analysis. Biometrics (1999) 1.89
Tumor markers in the diagnosis of primary bladder cancer. A systematic review. J Urol (2003) 1.86
Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med (2000) 1.80
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach. Stat Med (2005) 1.72
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol (2007) 1.71
Meta-analysis, funnel plots and sensitivity analysis. Biostatistics (2000) 1.67
Multivariate meta-analysis. Stat Med (2003) 1.65
A comparison of heterogeneity variance estimators in combining results of studies. Stat Med (2007) 1.57
Generalized least squares for the synthesis of correlated information. Biostatistics (2003) 1.32
How does study quality affect the results of a diagnostic meta-analysis? BMC Med Res Methodol (2005) 1.20
Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. J Clin Epidemiol (2004) 1.01
Combining multiple outcome measures in a meta-analysis: an application. Stat Med (2003) 0.95
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med (2009) 7.24
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet (2007) 6.57
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med (2004) 5.67
Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ (2010) 5.60
Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation (2008) 5.20
New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet (2009) 5.12
White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol (2003) 5.04
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet (2009) 4.63
Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med (2005) 4.45
Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87
Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. JAMA (2002) 3.42
Mapping of a major locus that determines telomere length in humans. Am J Hum Genet (2004) 3.33
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet (2010) 3.15
Common variants near TERC are associated with mean telomere length. Nat Genet (2010) 2.98
How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med (2005) 2.95
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol (2008) 2.93
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis (2010) 2.67
Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke (2006) 2.64
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol (2008) 2.48
Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol (2011) 2.37
Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet (2003) 2.27
Genetically determined height and coronary artery disease. N Engl J Med (2015) 2.24
A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B (2006) 2.23
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Biostatistical aspects of genome-wide association studies. Biom J (2008) 2.13
A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet (2009) 2.09
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05
Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol (2009) 2.01
Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J (2004) 1.99
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Serious complications of local anaesthesia for cataract surgery: a 1 year national survey in the United Kingdom. Br J Ophthalmol (2006) 1.96
Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence. Lancet (2002) 1.91
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89
The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol (2005) 1.88
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). Eur Urol (2012) 1.88
Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol (2007) 1.86
Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med (2007) 1.83
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ (2012) 1.80
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. J Natl Cancer Inst (2010) 1.79
An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics (2007) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach. Stat Med (2005) 1.72
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Clinical and cost-effectiveness of a new nurse-led continence service: a randomised controlled trial. Br J Gen Pract (2005) 1.68
Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet (2011) 1.60
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2012) 1.52
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res (2004) 1.47
Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses. Int J Epidemiol (2008) 1.45
A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet (2008) 1.43
A general framework for parametric survival analysis. Stat Med (2014) 1.43
Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med (2006) 1.42
Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med (2007) 1.40
Effect of NHS walk-in centre on local primary healthcare services: before and after observational study. BMJ (2003) 1.40
The prevalence of nystagmus: the Leicestershire nystagmus survey. Invest Ophthalmol Vis Sci (2009) 1.35
Evidence-based sample size calculations based upon updated meta-analysis. Stat Med (2007) 1.35
Choosing the relative survival method for cancer survival estimation. Eur J Cancer (2011) 1.34
Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics (2006) 1.27
Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer (2011) 1.27
An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am J Epidemiol (2004) 1.26
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ (2004) 1.24
Methods for meta-analyses of genome-wide association studies: critical assessment of empirical evidence. Am J Epidemiol (2012) 1.24
Estimating net survival in population-based cancer studies. Int J Cancer (2013) 1.24
Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med (2005) 1.23